Back to Search
Start Over
FDA: Exblifep Approved for Complicated Urinary Tract Infections: Cefepime/enmetazobactam was granted a 5-year exclusivity extension under GAIN Act legislation
- Source :
- Drug Topics. June, 2024, Vol. 168 Issue 5, p31, 1 p.
- Publication Year :
- 2024
-
Abstract
- The FDA approved cefepime/enmetazobactam (Exblifep) in February 2024 for the treatment of complicated urinary tract infections (cUTI) including pyelonephritis caused by designated susceptible microorganisms in patients 18 years and older. [...]
Details
- Language :
- English
- ISSN :
- 00126616
- Volume :
- 168
- Issue :
- 5
- Database :
- Gale General OneFile
- Journal :
- Drug Topics
- Publication Type :
- Periodical
- Accession number :
- edsgcl.798700893